Clinical trial
A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment…
NCT00459745 · Shionogi, Industry · Completed
Key facts
| NCT number | NCT00459745 |
|---|---|
| Title | A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia |
| Official title | A Multi-Center, Prospective, Longitudinal, Randomized, Double-Blind, Phase III Study to Evaluate the Efficacy and Safety of Daily Administration of Pravastatin 40 mg or Fenofibrate 160 mg or Pravafen (the Combination of Pravastatin and Fenofibrate 40/160 mg) for 12 Weeks Followed by a 52-Week… |
| Lead sponsor | Shionogi, Industry |
| Collaborators | Integrium Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Combined Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Pravafen, Pravastatin, Fenofibrate |
| Enrollment | 481 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Jul 1, 2009 |
| First posted | Apr 12, 2007 |
| Last update posted | Apr 24, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: